Skip to main content
MedPathMedPath Home
Clinical Trials/RPCEC00000275
RPCEC00000275
Completed
未知

Results of antimicrobial stewardship program in a tertiary care hospital: ambispective cohort study - PROGEAN-FARM

Pharmaceutical Promotion and Prevention Research Group0 sites514 target enrollmentMay 30, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInfectious diseasesCommunicable DiseasesInfectionEnvironmental Illness

Overview

Phase
未知
Intervention
Not specified
Conditions
Infectious diseases
Sponsor
Pharmaceutical Promotion and Prevention Research Group
Enrollment
514
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Pharmaceutical Promotion and Prevention Research Group

Eligibility Criteria

Inclusion Criteria

  • •1\. Patient older than 18 years.
  • •2\. Patients who, within their pharmacotherapy, have a minimum prescribed one of the following antibiotics:
  • •Penicillins: Piperacillin / Tazobactam.
  • •Cephalosporins: Ceftriaxone, Ceftazidime, Cefepime, Ceftaroline.
  • •Carbapenems: Meropenem, Doripenem, Imipenem / Cilastatin, Ertapenem.
  • •Quinolones: Ciprofloxacin.
  • •Glycopeptides: Vancomycin.
  • •Polymyxins: Polymyxin B, Colistin
  • •Oxazolidinones: Linezolid.
  • •Cyclic lipopeptides: Daptomycin.

Exclusion Criteria

  • •1\. Patients without the first evaluation by the treating medical specialty.
  • •2\. Patients receiving extracorporeal membrane oxygenation (ECMO).
  • •3\. Patients with cystic fibrosis. and. Administration of antimicrobials subcutaneously, intraperitoneally or intrathecally.
  • •4\. Patients admitted to surgery and hemodynamics.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
The impact of an antimicrobial stewardship team on the appropriateness of antimicrobialtherapy in sepsis
ACTRN12618000116224Alfred Hospital Pharmacy Department 120
Completed
Not Applicable
Antibiotic prescribing in an English secondary care setting before and during the COVID-19 pandemic
ISRCTN14825813niversity of Hertfordshire880
Not yet recruiting
Not Applicable
Study to rationalize antibiotic usage in NICHealth Condition 1: P369- Bacterial sepsis of newborn, unspecifiedHealth Condition 2: P399- Infection specific to the perinatal period, unspecified
CTRI/2021/05/033353KASTURBA MEDICAL COLLEGE MANIPA
Completed
Not Applicable
Exploratory study on the effects of antimicrobial therapy for refractory uveitis due to sarcoidosis.Sarcoidosis
JPRN-UMIN000018247Tokyo medical and dental university10
Completed
Not Applicable
Study of efficiency of Gana dhoop as fumigating agent in comparison with formali
CTRI/2022/11/047603KIRAN KULKARNI